Marco Senzolo Selected Research

Propranolol (Inderal)

12/2009	Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding?
10/2006	The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Senzolo Research Topics

Disease

61	Fibrosis (Cirrhosis) 03/2024 - 07/2006
29	Hemorrhage 01/2024 - 10/2006
23	Thrombosis (Thrombus) 02/2024 - 09/2006
20	Liver Diseases (Liver Disease) 12/2023 - 05/2004
16	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 12/2006
14	Infections 01/2022 - 09/2007
11	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 11/2006
10	End Stage Liver Disease 02/2024 - 07/2006
8	Bacterial Infections (Bacterial Infection) 03/2024 - 10/2006
7	Inflammation (Inflammations) 11/2023 - 01/2015
7	Neoplasms (Cancer) 01/2022 - 07/2011
6	Portal Hypertension 02/2024 - 07/2006
6	Ascites 01/2023 - 07/2006
5	Thrombophilia 01/2023 - 09/2009
5	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 01/2008
4	Hepatic Encephalopathy 01/2023 - 07/2006
4	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2021 - 04/2005
3	Hepatitis C 01/2017 - 01/2005
3	Hepatitis 01/2016 - 01/2005
3	Hepatitis B 02/2015 - 01/2005
3	Brain Diseases (Brain Disorder) 03/2009 - 11/2006
2	Disease Progression 01/2023 - 01/2023
2	Reinfection 01/2023 - 01/2016
2	Invasive Fungal Infections 12/2020 - 11/2020
2	Pathologic Constriction (Stenosis) 05/2020 - 12/2016
2	Liver Failure 12/2019 - 08/2010
2	Peritonitis 01/2017 - 04/2016
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2016 - 09/2008
2	Chronic Hepatitis C 01/2016 - 09/2014
2	Central Pontine Myelinolysis 06/2015 - 03/2009
2	Renal Insufficiency (Renal Failure) 04/2010 - 08/2008
1	Rare Diseases (Rare Disease) 02/2024
1	Ischemic Stroke 01/2024
1	Atrial Fibrillation 12/2023
1	Hyponatremia 10/2023
1	Thrombocytopenia (Thrombopenia) 02/2023
1	Acute Kidney Injury (Acute Renal Failure) 02/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Alcoholic Fatty Liver 02/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Thrombocytosis (Thrombocythemia) 01/2022
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 11/2021
1	Malnutrition (Nutritional Deficiencies) 03/2021
1	Sarcopenia 03/2021

Drug/Important Bio-Agent (IBA)

15	AnticoagulantsIBA 01/2024 - 09/2008
8	Hemostatics (Antihemorrhagics)IBA 03/2024 - 08/2010
8	Thrombin FDA Link 10/2023 - 09/2009
8	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2005
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2011
4	ThrombomodulinIBA 10/2023 - 10/2021
4	CreatinineIBA 10/2023 - 04/2010
3	Vitamin K FDA Link 01/2024 - 11/2012
3	SodiumIBA 10/2023 - 07/2006
3	Cytidine Triphosphate (CTP)IBA 10/2023 - 07/2006
3	von Willebrand FactorIBA 02/2023 - 10/2020
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023 - 09/2009
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021 - 09/2008
3	Heparin (Liquaemin)FDA LinkGeneric 08/2020 - 05/2009
3	InterferonsIBA 01/2016 - 02/2006
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 12/2021
2	Plasminogen Activator Inhibitor 1IBA 01/2023 - 01/2022
2	Fibrinolysin FDA Link 01/2023 - 12/2021
2	Thromboplastin (Tissue Factor)IBA 01/2022 - 01/2021
2	AmmoniaIBA 03/2021 - 12/2019
2	Amino Acids FDA Link 03/2021 - 12/2019
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2019 - 09/2008
2	TerlipressinIBA 01/2017 - 04/2010
2	AlbuminsIBA 02/2011 - 04/2010
2	Propranolol (Inderal)FDA LinkGeneric 12/2009 - 10/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2005 - 10/2002
1	Thrombopoietin (c-mpl Ligand)IBA 03/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	hepatitis B hyperimmune globulinIBA 01/2023
1	PlasminogenIBA 07/2022
1	RivaroxabanIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Nucleic AcidsIBA 12/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2021
1	Fondaparinux (Arixtra)FDA Link 10/2021
1	cyclo(Arg-Pro) (CI 4)IBA 07/2021
1	MyostatinIBA 03/2021
1	Hormones (Hormone)IBA 03/2021
1	VitaminsIBA 03/2021

Therapy/Procedure

57	Liver Transplantation 02/2024 - 01/2005
21	Therapeutics 01/2024 - 04/2005
14	Transjugular Intrahepatic Portasystemic Shunt 02/2024 - 07/2006
14	Surgical Portasystemic Shunt (Portosystemic Shunt) 02/2024 - 09/2006
8	Transplantation 01/2023 - 10/2008
5	Contraindications 10/2023 - 11/2012
2	Critical Care (Surgical Intensive Care) 12/2020 - 07/2019
2	Stents 05/2020 - 12/2016
2	Heart Transplantation (Grafting, Heart) 03/2009 - 10/2002
1	Drug Therapy (Chemotherapy) 01/2024
1	Ligation 10/2023
1	Radiofrequency Ablation 11/2021
1	Argon Plasma Coagulation 11/2021